Reviewed,
UniProtKB/Swiss-Prot P51149 (RAB7A_HUMAN)
Last modified
June 16, 2009.
Version 100.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Ras-related protein Rab-7a | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 207 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Involved in late endocytic transport. Contributes to the maturation of phagosomes (acidification). Ref.8 Ref.10 |
| Subunit structure | |
| Subcellular location | Late endosome. Lysosome. Cytoplasmic vesicle › phagosome. Melanosome. Note: Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Ref.10 Ref.9 Ref.13 |
| Tissue specificity | Widely expressed; high expression found in skeletal muscle. Ref.17 |
| Involvement in disease | Defects in RAB7A are the cause of Charcot-Marie-Tooth disease type 2B (CMT2B) [MIM:600882]; also known as hereditary motor and sensory neuropathy II (HMSN2). CMT2B is a form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy or CMT1, and primary peripheral axonal neuropathy or CMT2. Neuropathies of the CMT2 group are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. CMT2B is clinically characterized by marked distal muscle weakness and a high frequency of foot ulcers, infections and amputations of the toes. CMT2B inheritance is autosomal dominant. Ref.17 Ref.18 Ref.19 |
| Sequence similarities | Belongs to the small GTPase superfamily. Rab family. |
| Sequence caution | The sequence BAA91390.1 differs from that shown. Reason: Erroneous translation. Wrong choice of frame. The sequence BAF83410.1 differs from that shown. Reason: Erroneous translation. Wrong choice of frame. The sequence EAW79303.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| EIF1B | O60739 | 1 | EBI-1056089,EBI-1043343 | |
| VHL | P40337 | 1 | EBI-1056089,EBI-301246 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 207 | 207 | Ras-related protein Rab-7a | PRO_0000121121 | |||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 15 – 22 | 8 | GTP By similarity | ||||||||||||||||||||||||||||||||||
| Nucleotide binding | 63 – 67 | 5 | GTP By similarity | ||||||||||||||||||||||||||||||||||
| Nucleotide binding | 125 – 128 | 4 | GTP By similarity | ||||||||||||||||||||||||||||||||||
| Motif | 37 – 45 | 9 | Effector region By similarity | ||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||
| Modified residue | 72 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||||||||||||
| Modified residue | 183 | 1 | Phosphotyrosine Ref.12 | ||||||||||||||||||||||||||||||||||
| Modified residue | 207 | 1 | Cysteine methyl ester By similarity | ||||||||||||||||||||||||||||||||||
| Lipidation | 205 | 1 | S-geranylgeranyl cysteine By similarity | ||||||||||||||||||||||||||||||||||
| Lipidation | 207 | 1 | S-geranylgeranyl cysteine By similarity | ||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||
| Natural variant | 32 | 1 | K → E: dbSNP rs11549759. | VAR_037886 | |||||||||||||||||||||||||||||||||
| Natural variant | 129 | 1 | L → F in CMT2B. Ref.17 | VAR_018722 | |||||||||||||||||||||||||||||||||
| Natural variant | 157 | 1 | K → N in CMT2B. Ref.19 | VAR_037887 | |||||||||||||||||||||||||||||||||
| Natural variant | 161 | 1 | N → T in CMT2B. Ref.18 | VAR_037888 | |||||||||||||||||||||||||||||||||
| Natural variant | 162 | 1 | V → M in CMT2B. Ref.17 | VAR_018723 | |||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||
| Mutagenesis | 8 | 1 | L → A: Abolishes interaction with RAB7 and reduces its localization to late endosomal/lysosomal compartments. Ref.16 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 10 | 1 | K → A: Abolishes interaction with RAB7 and localization to late endosomal/lysosomal compartments. Ref.16 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 22 | 1 | T → N: Abolishes localization on late endosomes, lysosomes and phagosomes and reduces phagosomal fusions. Abolishes association of RILP with the phagosomes. Ref.10 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 67 | 1 | Q → L: Does not abolish localization on late endosomes, lysosomes and phagosomes and does not reduce phagosomal fusions. Ref.10 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 180 | 1 | V → A: Abolishes interaction with RAB7 and localization to late endosomal/lysosomal compartments. Ref.16 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 182 | 1 | L → A: Does not abolish interaction with RAB7 and localization to late endosomal/lysosomal compartments. Does not abolish interaction with RAB7 and localization to late endosomal/lysosomal compartments; when associated with A-183. Ref.16 | ||||||||||||||||||||||||||||||||||
| Mutagenesis | 183 | 1 | Y → A: Does not abolish interaction with RAB7 and localization to late endosomal/lysosomal compartments. Does not abolish interaction with RAB7 and localization to late endosomal/lysosomal compartments; when associated with A-182. Ref.16 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 47 | 1 | T → I in AAD02565. Ref.3 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 108 | 1 | I → V in AAA86640. Ref.2 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 127 | 1 | I → V in AAA86640. Ref.2 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 180 | 1 | V → E in AAD02565. Ref.3 | ||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||
| Beta strand | 8 – 14 | 7 | |||||||||||||||||||||||||||||||||||
| Helix | 21 – 30 | 10 | |||||||||||||||||||||||||||||||||||
| Beta strand | 42 – 54 | 13 | |||||||||||||||||||||||||||||||||||
| Beta strand | 56 – 64 | 9 | |||||||||||||||||||||||||||||||||||
| Helix | 68 – 70 | 3 | |||||||||||||||||||||||||||||||||||
| Beta strand | 82 – 89 | 8 | |||||||||||||||||||||||||||||||||||
| Helix | 93 – 97 | 5 | |||||||||||||||||||||||||||||||||||
| Helix | 99 – 110 | 12 | |||||||||||||||||||||||||||||||||||
| Helix | 115 – 117 | 3 | |||||||||||||||||||||||||||||||||||
| Beta strand | 120 – 125 | 6 | |||||||||||||||||||||||||||||||||||
| Helix | 136 – 145 | 10 | |||||||||||||||||||||||||||||||||||
| Beta strand | 151 – 153 | 3 | |||||||||||||||||||||||||||||||||||
| Turn | 156 – 159 | 4 | |||||||||||||||||||||||||||||||||||
| Helix | 162 – 181 | 20 | |||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and expression analysis of the human Rab7 GTP-ase complementary deoxyribonucleic acid." Vitelli R., Chiariello M., Lattero D., Bruni C.B., Bucci C. Biochem. Biophys. Res. Commun. 229:887-890(1996) [PubMed: 8954989] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Placenta. |
| [2] | "Cloning and mapping of human Rab7 and Rab9 cDNA sequences and identification of a Rab9 pseudogene." Davies J.P., Cotter P.D., Ioannou Y.A. Genomics 41:131-134(1997) [PubMed: 9126495] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | Kim J.Y., Park Y.B. Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Liver. |
| [4] | "cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org)." Puhl H.L. III, Ikeda S.R., Aronstam R.S. Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [8] | "Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes." Cantalupo G., Alifano P., Roberti V., Bruni C.B., Bucci C. EMBO J. 20:683-693(2001) [PubMed: 11179213] [Abstract] Cited for: FUNCTION IN LATE ENDOCYTOSIS, INTERACTION WITH RILP. |
| [9] | "Proteomic analysis of early melanosomes: identification of novel melanosomal proteins." Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K., Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J., Hearing V.J., Hunt D.F., Appella E. J. Proteome Res. 2:69-79(2003) [PubMed: 12643545] [Abstract] Cited for: SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [10] | "Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP." Harrison R.E., Bucci C., Vieira O.V., Schroer T.A., Grinstein S. Mol. Cell. Biol. 23:6494-6506(2003) [PubMed: 12944476] [Abstract] Cited for: FUNCTION IN PHAGOSOMAL BIOGENESIS, MUTAGENESIS OF THR-22 AND GLN-67, SUBCELLULAR LOCATION. |
| [11] | "A unique region of RILP distinguishes it from its related proteins in its regulation of lysosomal morphology and interaction with Rab7 and Rab34." Wang T., Wong K.K., Hong W. Mol. Biol. Cell 15:815-826(2004) [PubMed: 14668488] [Abstract] Cited for: INTERACTION WITH RILP. |
| [12] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-183, MASS SPECTROMETRY. |
| [13] | "Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes." Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F. J. Proteome Res. 5:3135-3144(2006) [PubMed: 17081065] [Abstract] Cited for: SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [14] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72, MASS SPECTROMETRY. |
| [15] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [16] | "Structural basis for recruitment of RILP by small GTPase Rab7." Wu M., Wang T., Loh E., Hong W., Song H. EMBO J. 24:1491-1501(2005) [PubMed: 15933719] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN COMPLEX WITH RILP, MUTAGENESIS OF LEU-8; LYS-10; VAL-180; LEU-182 AND TYR-183. |
| [17] | "Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy." Verhoeven K., De Jonghe P., Coen K., Verpoorten N., Auer-Grumbach M., Kwon J.M., FitzPatrick D., Schmedding E., De Vriendt E., Jacobs A., Van Gerwen V., Wagner K., Hartung H.-P., Timmerman V. Am. J. Hum. Genet. 72:722-727(2003) [PubMed: 12545426] [Abstract] Cited for: VARIANTS CMT2B PHE-129 AND MET-162, TISSUE SPECIFICITY. |
| [18] | "A novel RAB7 mutation associated with ulcero-mutilating neuropathy." Houlden H., King R.H.M., Muddle J.R., Warner T.T., Reilly M.M., Orrell R.W., Ginsberg L. Ann. Neurol. 56:586-590(2004) [PubMed: 15455439] [Abstract] Cited for: VARIANT CMT2B THR-161. |
| [19] | "Charcot-Marie-Tooth disease due to a de novo mutation of the RAB7 gene." Meggouh F., Bienfait H.M.E., Weterman M.A.J., de Visser M., Baas F. Neurology 67:1476-1478(2006) [PubMed: 17060578] [Abstract] Cited for: VARIANT CMT2B ASN-157. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| X93499 mRNA. Translation: CAA63763.1. U44104 mRNA. Translation: AAA86640.1. AF050175 Genomic DNA. Translation: AAD02565.1. AF498942 mRNA. Translation: AAM21090.1. AK000826 mRNA. Translation: BAA91390.1. Sequence problems. AK290721 mRNA. Translation: BAF83410.1. Sequence problems. BC008721 mRNA. Translation: AAH08721.2. CH471052 Genomic DNA. Translation: EAW79303.1. Sequence problems. | |||||||||||||||||||
| IPI | IPI00016342. | ||||||||||||||||||
| PIR | JC5268. | ||||||||||||||||||
| RefSeq | NP_004628.4. | ||||||||||||||||||
| UniGene | Hs.15738 Hs.714710 | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| |||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | P51149. 12 interactions. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | P51149. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PeptideAtlas | P51149. | ||||||||||||||||||
| PRIDE | P51149. | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENSG00000075785. Homo sapiens. [Contig view] | ||||||||||||||||||
| GeneID | 7879. | ||||||||||||||||||
| KEGG | hsa:7879. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| GeneCards | GC03P129928. | ||||||||||||||||||
| H-InvDB | HIX0003657. | ||||||||||||||||||
| HGNC | HGNC:9788. RAB7A. | ||||||||||||||||||
| HPA | HPA006964. | ||||||||||||||||||
| MIM | 600882. phenotype. 602298. gene. | ||||||||||||||||||
| Orphanet | 64746. Autosomal dominant Charcot-Marie-Tooth disease, type 2. 99936. Autosomal dominant Charcot-Marie-Tooth disease, type 2B. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| HOVERGEN | P51149. | ||||||||||||||||||
| OMA | P51149. SMKSFDN. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Pathway_Interaction_DB | il12_2pathway. IL12-mediated signaling events. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | P51149. | ||||||||||||||||||
| Bgee | P51149. | ||||||||||||||||||
| CleanEx | HS_RAB7A. | ||||||||||||||||||
| GermOnline | ENSG00000075785. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR003579. GTPase_Rab. IPR013753. Ras. IPR001806. Ras_GTPase. IPR005225. Small_GTP_bd. [Graphical view] | ||||||||||||||||||
| Pfam | PF00071. Ras. 1 hit. [Graphical view] | ||||||||||||||||||
| PRINTS | PR00449. RASTRNSFRMNG. | ||||||||||||||||||
| SMART | SM00175. RAB. 1 hit. [Graphical view] | ||||||||||||||||||
| TIGRFAMs | TIGR00231. small_GTP. 1 hit. | ||||||||||||||||||
| PROSITE | PS51419. RAB. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other Resources | |||||||||||||||||||
| NextBio | 30336. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | RAB7A_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P51149 Secondary accession number(s): A8K3V6, Q9NWJ0, Q9UPB0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


